| 产品名称: | T-24 |
|---|---|
| 商品货号: | TS259498 |
| <strong>Cell line </strong>: | T-24 |
| DSMZ no. : | TS259498 |
| Species : | confirmed as human with IEF of AST, LDH, NP |
| Cell type : | urinary bladder carcinoma |
| Origin : | established from the primary tumor of an 81-year-old Caucasian woman with urinary bladder carcinoma (transitional cell carcinoma, grade III) in 1970; described in the literature to produce a variety of cytokines (e.g. G-CSF, IL-6 and SCF) and to carry a p53 mutation |
| Reference(s) : | 14579, 14410, 14409, 15223, 18168 |
| Biosafety level : | 1 |
| Permissions and restrictions : | A |
| <strong> </strong>: | DSMZ Scientific Data: |
| Morphology: | epitheloid adherent cells growing in monolayers; image; image |
| Medium : | 90% Dulbeccos MEM (4.5 g/L glucose) + 10% h.i. FBS |
| Subculture : | split confluent culture 1:5 twice a week using trypsin/EDTA; seed out at ca. 1-2 x 106 cells/80 cm2 |
| Incubation : | at 37 °C with 10% CO2 |
| Doubling time : | ca. 48 hours |
| Harvest : | cell harvest of ca. 10 x 106 cells/80 cm2 |
| Storage : | frozen with 70% medium, 20% FBS, 10% DMSO |
| Mycoplasma : | contamination was eliminated with Baytril (enrofloxacin), then negative in DAPI, microbiological culture, RNA hybridization, PCR assays |
| Immunology : | To inquire about expression of EpCAM and intermediate filaments, contact hilmar.quentmeier@dsmz.de. |
| Fingerprint : | multiplex PCR of minisatellite markers revealed a unique DNA profile |
| Cytogenetics : | human hypertriploid karyotype with 8% polyploidy - 70-75<3n>XX, -X, +7, -10, -16, -17, -18, +20, +22, +4mar, add(1)(q11), add(1)(p34), del(6)(q21), del(8)(p21), del(9)(p21), del(10)(p11), add(11)(p13), del(13)(q13q14), i(14q), der(15q21q), add(18)(p11) - matches published karyotype |
| Viruses : | ELISA: reverse transcriptase negative; PCR: EBV -, HBV -, HCV -, HHV-8 -, HIV-1 -, HIV-2 -, HTLV-I/II -, MLV -, SMRV - |
| 产品名称: | T-24 |
|---|---|
| 商品货号: | TS259498 |
| <strong>Cell line </strong>: | T-24 |
| DSMZ no. : | TS259498 |
| Species : | confirmed as human with IEF of AST, LDH, NP |
| Cell type : | urinary bladder carcinoma |
| Origin : | established from the primary tumor of an 81-year-old Caucasian woman with urinary bladder carcinoma (transitional cell carcinoma, grade III) in 1970; described in the literature to produce a variety of cytokines (e.g. G-CSF, IL-6 and SCF) and to carry a p53 mutation |
| Reference(s) : | 14579, 14410, 14409, 15223, 18168 |
| Biosafety level : | 1 |
| Permissions and restrictions : | A |
| <strong> </strong>: | DSMZ Scientific Data: |
| Morphology: | epitheloid adherent cells growing in monolayers; image; image |
| Medium : | 90% Dulbeccos MEM (4.5 g/L glucose) + 10% h.i. FBS |
| Subculture : | split confluent culture 1:5 twice a week using trypsin/EDTA; seed out at ca. 1-2 x 106 cells/80 cm2 |
| Incubation : | at 37 °C with 10% CO2 |
| Doubling time : | ca. 48 hours |
| Harvest : | cell harvest of ca. 10 x 106 cells/80 cm2 |
| Storage : | frozen with 70% medium, 20% FBS, 10% DMSO |
| Mycoplasma : | contamination was eliminated with Baytril (enrofloxacin), then negative in DAPI, microbiological culture, RNA hybridization, PCR assays |
| Immunology : | To inquire about expression of EpCAM and intermediate filaments, contact hilmar.quentmeier@dsmz.de. |
| Fingerprint : | multiplex PCR of minisatellite markers revealed a unique DNA profile |
| Cytogenetics : | human hypertriploid karyotype with 8% polyploidy - 70-75<3n>XX, -X, +7, -10, -16, -17, -18, +20, +22, +4mar, add(1)(q11), add(1)(p34), del(6)(q21), del(8)(p21), del(9)(p21), del(10)(p11), add(11)(p13), del(13)(q13q14), i(14q), der(15q21q), add(18)(p11) - matches published karyotype |
| Viruses : | ELISA: reverse transcriptase negative; PCR: EBV -, HBV -, HCV -, HHV-8 -, HIV-1 -, HIV-2 -, HTLV-I/II -, MLV -, SMRV - |